ABBV's Skyrizi and Rinvoq are expected to drive Q3 growth, offset Humira's ongoing decline and face rising competition in the ...
Protagonist Therapeutics (PTGX), and Shattuck Labs (STTK) as its top picks in the emerging technology sector. For Nektar, the firm cited the novel Treg mechanism used in its phase 3 asset ...
The redness faded. The itching subsided. Just when you thought it had finally cleared up, it got worse again.Even if the skin ...
Skyrizi and Rinvoq are growing fast, a blockbuster acquisition just closed, and the FDA handed AbbVie a fresh approval, yet ...
“When humans migrated around the world, our gut microbiomes came with us. We're now losing many of those ancient microbial ...
The AI-driven pharmaceutical R&D landscape has achieved a landmark breakthrough by successfully crossing the long-standing ...
Pfizer Inc_ NY HQ-by JHVEPhoto via iStock. Popular biopharmaceutical company Pfizer (PFE) plans to cut around 330 jobs at its Catania plant in Sicily. This is part of a broader re ...
Just over a year has passed since the Trump administration sent letters to 17 leading manufacturers demanding steps towards ...
In the MEERKAT and SANDCAT studies, vamikibart demonstrated sustained improvements in vision and reductions in macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results